123 related articles for article (PubMed ID: 16773539)
1. Activity-guided isolation of an antiandrogenic compound of Pygeum africanum.
Schleich S; Papaioannou M; Baniahmad A; Matusch R
Planta Med; 2006 May; 72(6):547-51. PubMed ID: 16773539
[TBL] [Abstract][Full Text] [Related]
2. NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.
Papaioannou M; Schleich S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
Invest New Drugs; 2010 Dec; 28(6):729-43. PubMed ID: 19771394
[TBL] [Abstract][Full Text] [Related]
3. Extracts from Pygeum africanum and other ethnobotanical species with antiandrogenic activity.
Schleich S; Papaioannou M; Baniahmad A; Matusch R
Planta Med; 2006 Jul; 72(9):807-13. PubMed ID: 16783690
[TBL] [Abstract][Full Text] [Related]
4. The natural compounds atraric acid and N-butylbenzene-sulfonamide as antagonists of the human androgen receptor and inhibitors of prostate cancer cell growth.
Roell D; Baniahmad A
Mol Cell Endocrinol; 2011 Jan; 332(1-2):1-8. PubMed ID: 20965230
[TBL] [Abstract][Full Text] [Related]
5. Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health.
Thompson RQ; Katz D; Sheehan B
J Pharm Biomed Anal; 2019 Jan; 163():162-169. PubMed ID: 30316061
[TBL] [Abstract][Full Text] [Related]
6. The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth.
Papaioannou M; Schleich S; Prade I; Degen S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
J Cell Mol Med; 2009 Aug; 13(8B):2210-2223. PubMed ID: 18627423
[TBL] [Abstract][Full Text] [Related]
7. Phytosterol Pygeum africanum regulates prostate cancer in vitro and in vivo.
Shenouda NS; Sakla MS; Newton LG; Besch-Williford C; Greenberg NM; MacDonald RS; Lubahn DB
Endocrine; 2007 Feb; 31(1):72-81. PubMed ID: 17709901
[TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic activity of anthranilic acid ester derivatives as novel lead structures to inhibit prostate cancer cell proliferation.
Roell D; Rösler TW; Degen S; Matusch R; Baniahmad A
Chem Biol Drug Des; 2011 Jun; 77(6):450-9. PubMed ID: 21439024
[TBL] [Abstract][Full Text] [Related]
9. Antiandrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin.
Zierau O; Morrissey C; Watson RW; Schwab P; Kolba S; Metz P; Vollmer G
Planta Med; 2003 Sep; 69(9):856-8. PubMed ID: 14598215
[TBL] [Abstract][Full Text] [Related]
10. Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth?
Yam J; Kreuter M; Drewe J
Planta Med; 2008 Jan; 74(1):33-8. PubMed ID: 18080233
[TBL] [Abstract][Full Text] [Related]
11. The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator.
Dotan N; Wasser SP; Mahajna J
Integr Cancer Ther; 2011 Jun; 10(2):148-59. PubMed ID: 21147815
[TBL] [Abstract][Full Text] [Related]
12. Antiandrogenic activity of resveratrol analogs in prostate cancer LNCaP cells.
Iguchi K; Toyama T; Ito T; Shakui T; Usui S; Oyama M; Iinuma M; Hirano K
J Androl; 2012; 33(6):1208-15. PubMed ID: 22700762
[TBL] [Abstract][Full Text] [Related]
13. Review of the experience and evidence of Pygeum africanum in urological practice.
Salinas-Casado J; Esteban-Fuertes M; Carballido-Rodríguez J; Cozar-Olmo JM
Actas Urol Esp (Engl Ed); 2020; 44(1):9-13. PubMed ID: 31627963
[TBL] [Abstract][Full Text] [Related]
14. A critical review of the pharmacology of the plant extract of Pygeum africanum in the treatment of LUTS.
Edgar AD; Levin R; Constantinou CE; Denis L
Neurourol Urodyn; 2007; 26(4):458-463. PubMed ID: 17397059
[TBL] [Abstract][Full Text] [Related]
15. Antiandrogenic activities of diesel exhaust particle extracts in PC3/AR human prostate carcinoma cells.
Kizu R; Okamura K; Toriba A; Mizokami A; Burnstein KL; Klinge CM; Hayakawa K
Toxicol Sci; 2003 Dec; 76(2):299-309. PubMed ID: 12970580
[TBL] [Abstract][Full Text] [Related]
16. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
[TBL] [Abstract][Full Text] [Related]
17. SAR based design of nicotinamides as a novel class of androgen receptor antagonists for prostate cancer.
Yang SH; Song CH; Van HT; Park E; Khadka DB; Gong EY; Lee K; Cho WJ
J Med Chem; 2013 Apr; 56(8):3414-8. PubMed ID: 23527816
[TBL] [Abstract][Full Text] [Related]
18. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
19. Flavonoid and botanical approaches to prostate health.
Katz AE
J Altern Complement Med; 2002 Dec; 8(6):813-21. PubMed ID: 12614534
[TBL] [Abstract][Full Text] [Related]
20. Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures.
Larré S; Camparo P; Comperat E; Boulbés D; Haddoum M; Baulande S; Soularue P; Costa P; Cussenot O
Asian J Androl; 2012 May; 14(3):499-504. PubMed ID: 22198631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
